Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pelacarsen sodium by Novartis for Aortic Valve Stenosis: Likelihood of Approval
Pelacarsen sodium is under clinical development by Novartis and currently in Phase II for Aortic Valve Stenosis. According to GlobalData,...
Data Insights
Pelacarsen sodium by Novartis for Cardiovascular Disease: Likelihood of Approval
Pelacarsen sodium is under clinical development by Novartis and currently in Phase III for Cardiovascular Disease. According to GlobalData, Phase...